Study of Chemo-Immunotherapy in Head and Neck Cancer Patients
NCT01149902
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Head and Neck Cancer
Interventions
BIOLOGICAL:
Cyclophosphamide, Docetaxel, Dendritic cells, OK-432
Sponsor
University of Yamanashi